Efficacy and safety of venetoclax and azacitidine for acute myeloid leukemia in China: a real-world single-center study

被引：0

作者：

Jie-Fei Bai ^{[1
]}

Ting Wang ^{[1
]}

Jiang-Tao Li ^{[2
]}

Chun-Li Zhang ^{[1
]}

Long Qian ^{[1
]}

Ya-Zi Yang ^{[1
]}

Xiao-Ya Yun ^{[1
]}

Jing-Jing Yin ^{[1
]}

Fei Zhao ^{[1
]}

Wei-Dong Ding ^{[1
]}

Bao-Li Xing ^{[1
]}

Shang-Yong Ning ^{[1
]}

Lei Pei ^{[1
]}

Xiao-Dong Xu ^{[1
]}

Hui Liu ^{[1
]}

Ru Feng ^{[1
]}

机构：

[1] Chinese Academy of Medical Sciences,Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine

[2] Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine

来源：

BMC Cancer | / 25卷 / 1期

关键词：

Acute myeloid leukemia; Hypomethylating agents; Venetoclax; Relapse; Refractory;

D O I：

10.1186/s12885-025-14167-z

中图分类号：

学科分类号：

摘要：

引用